Johns Hopkins Children's Center: Department of Allergy & Immunology

Baltimore, Maryland 21287

We've found

1 trials

at this facility

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Status: Upcoming, Phase III
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!